REDWOOD CITY, Calif., Jan. 21, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic ...

The webcast will be available on the company's website for two weeks following the completion of the call. About the Senza System and HF10 Therapy The Senza system is the only SCS system that delivers ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all-cash deal comes ...

Nevro (NVRO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

Diversity, equity and inclusion programs were created to help communities ... or felt a lack of belonging in majority-White corporate settings. These programs expanded on the Civil Rights Act ...

In the latest quarter, 11 analysts provided ratings for Nevro (NYSE:NVRO), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the ...